Ischemic cardiomyopathy (ICM) is the most prevalent type of chronic heart diseases in the United States and a common underlying etiology of congestive heart failure. Nonetheless the underlying molecular mechanism of ICM remains unclear. Moreover, the prognosis of chronic ICM is very poor if left untreated. Therefore it is highly important to gain a better understanding of the disease mechanism and to identify specific biomarkers for early detection and treatment of ICM. Myofilament proteins in the sarcomeres not only play essential roles in cardiac contractility but also are critical elements in signal reception and transduction during the onset and progression to heart failure. The hypothesis is that post-myocardial infarction (MI) maladaptive cardiac remodeling can result in altered protein modifications in myofilaments that are associated with cardiac dysfunction and offer potential diagnostic and prognostic biomarkers of ICM. Although multiple myofilament post-translational modifications (PTMs) are believed to act in concert in regulating cardiac function, a comprehensive analysis of myofilament proteins simultaneously and assess all synergistic PTM changes related to cardiac function is lacking. Herein, we will employ an innovative integrated "top-down" protein mass spectrometry (MS)-based disease proteomics platform to simultaneously examine myofilament proteins extracted from healthy and diseased swine and human myocardium and identify all disease-related changes in myofilament modifications.
Aim 1 will identify altered protein modifications in myofilaments from diseased swine myocardium of post-MI ICM model and determine their functional consequences.
Aim 2 will determine myofilament alterations in end-stage failing human myocardium from ICM patients and their functional consequences.
Aim 3 will assess the functional effects of novel myofilament modifications in Ca2+-mediated cardiac muscle contraction and relaxation. Mechanical properties (the isometric force and the Ca2+-sensitivity of the force) will be measured in skinned myocardial preparations in parallel to proteomics experiments. Furthermore, we will assess regional systolic and diastolic function to establish mechanistic links between specific proteomic changes and in vivo and ex vivo cardiac function. With the completion of this project, we expect to identify multiple functionally significant alterations in myofilaments and understand how these alterations act in concert to modulate maladaptive signaling during post-MI left ventricular remodeling to failure. The success of our research will provide new insights into the mechanisms underlying ICM and will identify new candidate biomarkers for early detection of the presence and progression of ICM.

Public Health Relevance

Heart failure remains a leading cause of mortality and morbidity in the United States. Whereas the treatments for acute coronary syndromes have dramatically improved in the past decade, chronic heart disease is approaching epidemic levels in western countries. The success of our research will provide new insights into the mechanisms underlying chronic heart disease and will also identify new candidate biomarkers for early detection of the presence and progression of Ischemic cardiomyopathy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL109810-01A1
Application #
8446827
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Schwartz, Lisa
Project Start
2013-03-01
Project End
2017-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
1
Fiscal Year
2013
Total Cost
$376,250
Indirect Cost
$126,250
Name
University of Wisconsin Madison
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Gregorich, Zachery R; Chang, Ying-Hua; Ge, Ying (2014) Proteomics in heart failure: top-down or bottom-up? Pflugers Arch 466:1199-209
Xiu, Lichen; Valeja, Santosh G; Alpert, Andrew J et al. (2014) Effective protein separation by coupling hydrophobic interaction and reverse phase chromatography for top-down proteomics. Anal Chem 86:7899-906
Peng, Ying; Gregorich, Zachery R; Valeja, Santosh G et al. (2014) Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein phosphorylation after acute myocardial infarction. Mol Cell Proteomics 13:2752-64
Guner, Huseyin; Close, Patrick L; Cai, Wenxuan et al. (2014) MASH Suite: a user-friendly and versatile software interface for high-resolution mass spectrometry data interpretation and visualization. J Am Soc Mass Spectrom 25:464-70
Gregorich, Zachery R; Ge, Ying (2014) Top-down proteomics in health and disease: challenges and opportunities. Proteomics 14:1195-210
Peng, Ying; Ayaz-Guner, Serife; Yu, Deyang et al. (2014) Top-down mass spectrometry of cardiac myofilament proteins in health and disease. Proteomics Clin Appl 8:554-68
Zhao, Dong S; Gregorich, Zachery R; Ge, Ying (2013) High throughput screening of disulfide-containing proteins in a complex mixture. Proteomics 13:3256-60
Peng, Ying; Yu, Deyang; Gregorich, Zachery et al. (2013) In-depth proteomic analysis of human tropomyosin by top-down mass spectrometry. J Muscle Res Cell Motil 34:199-210
Chen, Xin; Ge, Ying (2013) Ultrahigh pressure fast size exclusion chromatography for top-down proteomics. Proteomics 13:2563-6